Changing focus in type 2 diabetes from glucose to cardiovascular risk management
Changing focus in type 2 diabetes from glucose to cardiovascular risk management
with a focus on SGLT2-inhibitors
Bernard Charbonnel
Professor of Endocrinology and Metabolic Diseases
University of Nantes, France
Changing focus in type 2 diabetes
Two main questions
- Is Type 2 Diabetes more a cardio-vascular disease than a metabolic disease?
in other terms, is the management of
type 2 Diabetes driven
by blood glucose control
or by cardio-vascular events prevention?
- Which lessons from
the outcome studies?
Of course, Diabetes is a cardio-vascular disease
50 % of the diabetic patients die from an heart attack
2/3 of patients in intensive care cardiology units have some kind of glucose intolerance
High prevalence of strokes in diabetic patients
Heart Failure is becoming the most frequent and serious cardio-vascular complication of Diabetes
